0.2 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 OMICRON (LP.8.1) 0.05 MG/ML Prefilled Syringe [Mnexspike 2025-2026]
RxNorm concept 2722661, branded drug (sbd). Prescribable name: mNEXSPIKE 2025-2026 vaccine, 0.2 ML Prefilled Syringe.
- RxCUI
- 2722661
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2722661 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
0.2 ML Mnexspike 2025-2026 0.05 MG/ML Prefilled Syringe; mNEXSPIKE 2025-2026 vaccine, 0.2 ML Prefilled Syringe
Related concepts
- SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 OMICRON (LP.8.1) 0.05 MG/ML (SCDC, consists of)
- SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 OMICRON (LP.8.1) 0.05 MG/ML [Mnexspike 2025-2026] (SBDC, consists of)
- Prefilled Syringe (DF, has dose form)
- Mnexspike 2025-2026 (BN, has ingredient)
- 0.2 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 OMICRON (LP.8.1) 0.05 MG/ML Prefilled Syringe (SCD, tradename of)
Linked data
NDCs
- 80777040017
- 80777040060
- 80777040061
- 80777040062
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2722661 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2722661 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2722661. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.